Allergen (AGN) PT Lowered to $140 at RBC Capital; 'Upside Limited'
Tweet Send to a Friend
RBC Capital analyst Randall Stanicky lowered the price target on Allergen (NYSE: AGN) to $140.00 (from $165.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
